The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global NMN Intravenous Market Research Report 2024
Synopsis
NMN is the next generation of anti-ageing therapy. NMN, a rejuvenating ingredient, is absorbed into the body and converted into a substance called NAD+ when it is delivered to all parts of the body.
The global NMN Intravenous market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for NMN Intravenous is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for NMN Intravenous is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for NMN Intravenous in Clinic is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of NMN Intravenous include Invigor Medical, Empower Pharmacy, Azivmedics, Reset IV, Gtrsante, Mobileivmedics, Conciergemdla, The Wellness Lab and Rocky Mountain Ivmedics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for NMN Intravenous, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding NMN Intravenous.
Report Scope
The NMN Intravenous market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global NMN Intravenous market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the NMN Intravenous companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Invigor Medical
Empower Pharmacy
Azivmedics
Reset IV
Gtrsante
Mobileivmedics
Conciergemdla
The Wellness Lab
Rocky Mountain Ivmedics
Seaside Skin Care
Revivme
Premiumhealth
Effect Doctors
Nadclinic
Thedripclub
Next-health
Segment by Type
Hybrid Type
Pure NAD+ Type
Segment by Application
Clinic
Hospital
Residential
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of NMN Intravenous companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
NMN is the next generation of anti-ageing therapy. NMN, a rejuvenating ingredient, is absorbed into the body and converted into a substance called NAD+ when it is delivered to all parts of the body.
The global NMN Intravenous market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for NMN Intravenous is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for NMN Intravenous is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for NMN Intravenous in Clinic is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of NMN Intravenous include Invigor Medical, Empower Pharmacy, Azivmedics, Reset IV, Gtrsante, Mobileivmedics, Conciergemdla, The Wellness Lab and Rocky Mountain Ivmedics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for NMN Intravenous, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding NMN Intravenous.
Report Scope
The NMN Intravenous market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global NMN Intravenous market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the NMN Intravenous companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Invigor Medical
Empower Pharmacy
Azivmedics
Reset IV
Gtrsante
Mobileivmedics
Conciergemdla
The Wellness Lab
Rocky Mountain Ivmedics
Seaside Skin Care
Revivme
Premiumhealth
Effect Doctors
Nadclinic
Thedripclub
Next-health
Segment by Type
Hybrid Type
Pure NAD+ Type
Segment by Application
Clinic
Hospital
Residential
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of NMN Intravenous companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global NMN Intravenous Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Hybrid Type
1.2.3 Pure NAD+ Type
1.3 Market by Application
1.3.1 Global NMN Intravenous Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Residential
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global NMN Intravenous Market Perspective (2019-2030)
2.2 NMN Intravenous Growth Trends by Region
2.2.1 Global NMN Intravenous Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 NMN Intravenous Historic Market Size by Region (2019-2024)
2.2.3 NMN Intravenous Forecasted Market Size by Region (2025-2030)
2.3 NMN Intravenous Market Dynamics
2.3.1 NMN Intravenous Industry Trends
2.3.2 NMN Intravenous Market Drivers
2.3.3 NMN Intravenous Market Challenges
2.3.4 NMN Intravenous Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top NMN Intravenous Players by Revenue
3.1.1 Global Top NMN Intravenous Players by Revenue (2019-2024)
3.1.2 Global NMN Intravenous Revenue Market Share by Players (2019-2024)
3.2 Global NMN Intravenous Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by NMN Intravenous Revenue
3.4 Global NMN Intravenous Market Concentration Ratio
3.4.1 Global NMN Intravenous Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by NMN Intravenous Revenue in 2023
3.5 NMN Intravenous Key Players Head office and Area Served
3.6 Key Players NMN Intravenous Product Solution and Service
3.7 Date of Enter into NMN Intravenous Market
3.8 Mergers & Acquisitions, Expansion Plans
4 NMN Intravenous Breakdown Data by Type
4.1 Global NMN Intravenous Historic Market Size by Type (2019-2024)
4.2 Global NMN Intravenous Forecasted Market Size by Type (2025-2030)
5 NMN Intravenous Breakdown Data by Application
5.1 Global NMN Intravenous Historic Market Size by Application (2019-2024)
5.2 Global NMN Intravenous Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America NMN Intravenous Market Size (2019-2030)
6.2 North America NMN Intravenous Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America NMN Intravenous Market Size by Country (2019-2024)
6.4 North America NMN Intravenous Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe NMN Intravenous Market Size (2019-2030)
7.2 Europe NMN Intravenous Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe NMN Intravenous Market Size by Country (2019-2024)
7.4 Europe NMN Intravenous Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific NMN Intravenous Market Size (2019-2030)
8.2 Asia-Pacific NMN Intravenous Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific NMN Intravenous Market Size by Region (2019-2024)
8.4 Asia-Pacific NMN Intravenous Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America NMN Intravenous Market Size (2019-2030)
9.2 Latin America NMN Intravenous Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America NMN Intravenous Market Size by Country (2019-2024)
9.4 Latin America NMN Intravenous Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa NMN Intravenous Market Size (2019-2030)
10.2 Middle East & Africa NMN Intravenous Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa NMN Intravenous Market Size by Country (2019-2024)
10.4 Middle East & Africa NMN Intravenous Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Invigor Medical
11.1.1 Invigor Medical Company Detail
11.1.2 Invigor Medical Business Overview
11.1.3 Invigor Medical NMN Intravenous Introduction
11.1.4 Invigor Medical Revenue in NMN Intravenous Business (2019-2024)
11.1.5 Invigor Medical Recent Development
11.2 Empower Pharmacy
11.2.1 Empower Pharmacy Company Detail
11.2.2 Empower Pharmacy Business Overview
11.2.3 Empower Pharmacy NMN Intravenous Introduction
11.2.4 Empower Pharmacy Revenue in NMN Intravenous Business (2019-2024)
11.2.5 Empower Pharmacy Recent Development
11.3 Azivmedics
11.3.1 Azivmedics Company Detail
11.3.2 Azivmedics Business Overview
11.3.3 Azivmedics NMN Intravenous Introduction
11.3.4 Azivmedics Revenue in NMN Intravenous Business (2019-2024)
11.3.5 Azivmedics Recent Development
11.4 Reset IV
11.4.1 Reset IV Company Detail
11.4.2 Reset IV Business Overview
11.4.3 Reset IV NMN Intravenous Introduction
11.4.4 Reset IV Revenue in NMN Intravenous Business (2019-2024)
11.4.5 Reset IV Recent Development
11.5 Gtrsante
11.5.1 Gtrsante Company Detail
11.5.2 Gtrsante Business Overview
11.5.3 Gtrsante NMN Intravenous Introduction
11.5.4 Gtrsante Revenue in NMN Intravenous Business (2019-2024)
11.5.5 Gtrsante Recent Development
11.6 Mobileivmedics
11.6.1 Mobileivmedics Company Detail
11.6.2 Mobileivmedics Business Overview
11.6.3 Mobileivmedics NMN Intravenous Introduction
11.6.4 Mobileivmedics Revenue in NMN Intravenous Business (2019-2024)
11.6.5 Mobileivmedics Recent Development
11.7 Conciergemdla
11.7.1 Conciergemdla Company Detail
11.7.2 Conciergemdla Business Overview
11.7.3 Conciergemdla NMN Intravenous Introduction
11.7.4 Conciergemdla Revenue in NMN Intravenous Business (2019-2024)
11.7.5 Conciergemdla Recent Development
11.8 The Wellness Lab
11.8.1 The Wellness Lab Company Detail
11.8.2 The Wellness Lab Business Overview
11.8.3 The Wellness Lab NMN Intravenous Introduction
11.8.4 The Wellness Lab Revenue in NMN Intravenous Business (2019-2024)
11.8.5 The Wellness Lab Recent Development
11.9 Rocky Mountain Ivmedics
11.9.1 Rocky Mountain Ivmedics Company Detail
11.9.2 Rocky Mountain Ivmedics Business Overview
11.9.3 Rocky Mountain Ivmedics NMN Intravenous Introduction
11.9.4 Rocky Mountain Ivmedics Revenue in NMN Intravenous Business (2019-2024)
11.9.5 Rocky Mountain Ivmedics Recent Development
11.10 Seaside Skin Care
11.10.1 Seaside Skin Care Company Detail
11.10.2 Seaside Skin Care Business Overview
11.10.3 Seaside Skin Care NMN Intravenous Introduction
11.10.4 Seaside Skin Care Revenue in NMN Intravenous Business (2019-2024)
11.10.5 Seaside Skin Care Recent Development
11.11 Revivme
11.11.1 Revivme Company Detail
11.11.2 Revivme Business Overview
11.11.3 Revivme NMN Intravenous Introduction
11.11.4 Revivme Revenue in NMN Intravenous Business (2019-2024)
11.11.5 Revivme Recent Development
11.12 Premiumhealth
11.12.1 Premiumhealth Company Detail
11.12.2 Premiumhealth Business Overview
11.12.3 Premiumhealth NMN Intravenous Introduction
11.12.4 Premiumhealth Revenue in NMN Intravenous Business (2019-2024)
11.12.5 Premiumhealth Recent Development
11.13 Effect Doctors
11.13.1 Effect Doctors Company Detail
11.13.2 Effect Doctors Business Overview
11.13.3 Effect Doctors NMN Intravenous Introduction
11.13.4 Effect Doctors Revenue in NMN Intravenous Business (2019-2024)
11.13.5 Effect Doctors Recent Development
11.14 Nadclinic
11.14.1 Nadclinic Company Detail
11.14.2 Nadclinic Business Overview
11.14.3 Nadclinic NMN Intravenous Introduction
11.14.4 Nadclinic Revenue in NMN Intravenous Business (2019-2024)
11.14.5 Nadclinic Recent Development
11.15 Thedripclub
11.15.1 Thedripclub Company Detail
11.15.2 Thedripclub Business Overview
11.15.3 Thedripclub NMN Intravenous Introduction
11.15.4 Thedripclub Revenue in NMN Intravenous Business (2019-2024)
11.15.5 Thedripclub Recent Development
11.16 Next-health
11.16.1 Next-health Company Detail
11.16.2 Next-health Business Overview
11.16.3 Next-health NMN Intravenous Introduction
11.16.4 Next-health Revenue in NMN Intravenous Business (2019-2024)
11.16.5 Next-health Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
